Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Petersen

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolatesPeter J Petersen, T Z Wang, Russell G Dushin, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infectionPeter J Petersen, C Hal Jones, Aranapakam M Venkatesan, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Tigecycline: a case studyEvan Loh, Evelyn Ellis-Grosse, Peter J Petersen, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Synthesis and activity of novel benzoxazole derivatives of mannopeptimycin glycopeptide antibioticsPhaik-Eng Sum, David How, Nancy Torres, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test methodPatricia A Bradford, Peter J Petersen, Mairead Young, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155C Hal Jones, Alexey Ruzin, Margareta Tuckman, et al.
Journal of Clinical Microbiology|May 25, 2007
Validation and reproducibility assessment of tigecycline MIC determinations by EtestAnne Bolmström, Asa Karlsson, Anette Engelhardt, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2008
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489Peter J Petersen, C Hal Jones, Aranapakam M Venkatesan, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogensPeter J Petersen, Patricia A Bradford, William J Weiss, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Novel ether derivatives of mannopeptimycin glycopeptide antibioticPhaik-Eng Sum, David How, Nancy Torres, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolatesPeter J Petersen, T Z Wang, Russell G Dushin, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infectionPeter J Petersen, C Hal Jones, Aranapakam M Venkatesan, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Tigecycline: a case studyEvan Loh, Evelyn Ellis-Grosse, Peter J Petersen, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Synthesis and activity of novel benzoxazole derivatives of mannopeptimycin glycopeptide antibioticsPhaik-Eng Sum, David How, Nancy Torres, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test methodPatricia A Bradford, Peter J Petersen, Mairead Young, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155C Hal Jones, Alexey Ruzin, Margareta Tuckman, et al.
Journal of Clinical Microbiology|May 25, 2007
Validation and reproducibility assessment of tigecycline MIC determinations by EtestAnne Bolmström, Asa Karlsson, Anette Engelhardt, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2008
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489Peter J Petersen, C Hal Jones, Aranapakam M Venkatesan, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogensPeter J Petersen, Patricia A Bradford, William J Weiss, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Novel ether derivatives of mannopeptimycin glycopeptide antibioticPhaik-Eng Sum, David How, Nancy Torres, et al.
Pageof 5